Evidence map›Paper›PMID 22747098›Full record

ArticleJournal of chemical information and modeling2012

Virtual target screening: validation using kinase inhibitors.

Daniel N Santiago, Yuri Pevzner, Ashley A Durand, MinhPhuong Tran, Rachel R Scheerer, Kenyon Daniel, Shen-Shu Sung, H Lee Woodcock, Wayne C Guida, Wesley H Brooks

Abstract read
In one paragraph

Article in Journal of chemical information and modeling, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. AutoRevDock: An open-source toolkit for scalable reverse docking.Protein science : a publication of the Protein Society · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Daniel N SantiagoDepartment of Chemistry, University of South Florida, Tampa, Florida 33620, USA.
Yuri Pevzner
Ashley A Durand
MinhPhuong Tran
Rachel R Scheerer
Kenyon Daniel
Shen-Shu Sung
H Lee Woodcock
Wayne C Guida
Wesley H Brooks

Funding

Modern Drug Resistance: Elucidation of Beta-Lactamase Mechanisms of ActionK22HL088341 · NHLBI · UNIVERSITY OF SOUTH FLORIDA · PI WOODCOCK III, HENRY LEE · 2009 to 2011
$486k
NHLBI NIH HHS 1K22HL088341-01A1NHLBI NIH HHS K22 HL088341
6 · The paper itself

Abstract

Computational methods involving virtual screening could potentially be employed to discover new biomolecular targets for an individual molecule of interest (MOI). However, existing scoring functions may not accurately differentiate proteins to which the MOI binds from a larger set of macromolecules in a protein structural database. An MOI will most likely have varying degrees of predicted binding affinities to many protein targets. However, correctly interpreting a docking score as a hit for the MOI docked to any individual protein can be problematic. In our method, which we term "Virtual Target Screening (VTS)", a set of small drug-like molecules are docked against each structure in the protein library to produce benchmark statistics. This calibration provides a reference for each protein so that hits can be identified for an MOI. VTS can then be used as tool for: drug repositioning (repurposing), specificity and toxicity testing, identifying potential metabolites, probing protein structures for allosteric sites, and testing focused libraries (collection of MOIs with similar chemotypes) for selectivity. To validate our VTS method, twenty kinase inhibitors were docked to a collection of calibrated protein structures. Here, we report our results where VTS predicted protein kinases as hits in preference to other proteins in our database. Concurrently, a graphical interface for VTS was developed.

Indexed as

User-Computer InterfaceCell Line, TumorCyclin-Dependent Kinase 2Databases, ProteinDrug ApprovalDrug Evaluation, PreclinicalHumansModels, MolecularProtein ConformationProtein Kinase InhibitorsProtein KinasesReproducibility of ResultsSmall Molecule LibrariesCyclin-Dependent Kinase 2Protein Kinase InhibitorsProtein KinasesSmall Molecule Libraries

Identifiers

PMID22747098
PMCPMC3488111

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.